Publication | Closed Access

Acetyl-11-keto-β-boswellic acid ameliorates cognitive deficits and reduces amyloid-β levels in APPswe/PS1dE9 mice through antioxidant and anti-inflammatory pathways

Neurodegenerative DiseasesAnti-inflammatory PathwaysMedicineBrain HealthAppswe/ps1de9 MiceAcetyl-11-keto-β-boswellic Acid AmelioratesNeurochemical BiomarkersNeuroprotectionNeurologyNeurosciencePharmacologyProtective Mechanisms